RxDoctor Payments Data

Kimberly Stotts

Psychiatric/Mental Health · Jonesboro, ARNPI 1528837945

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,424in general payments, 2019–2025

Across 263 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$844
  • Johnson & Johnson$832
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$631
  • AbbVie$570
  • Neurocrine Biosciences, Inc.$534
  • Otsuka America Pharmaceutical, Inc.$500
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$5,424100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,424 in reported general payments places this provider in the 90th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl13$18,814
AuvelityDextromethorphan Hbr/Bupropion15$17,347
Hydroxyzine Hcl18$426
Lamotrigine39$278
Bupropion XlBupropion Hcl19$142
Aripiprazole14$127
Venlafaxine Hcl ErVenlafaxine Hcl11$119
Alprazolam21$109
Trazodone Hcl21$80
Propranolol Hcl12$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$570$18,81413 claims
Axsome Therapeutics, Inc.Auvelity$844$17,34715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →